Codi QR

Comparison of Docetaxel, Doxorubicin and Cyclophosphamide (TAC) with 5-Fluorouracil, Doxorubicin and Cyclophosphamide (FAC) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase III Clinical Trial

Background: The present study aimed to compare the rates of complete clinical and pathologic response to docetaxel, doxorubicin and cyclophosphamide (TAC) vs. 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) as neoadjuvant chemotherapy in women with locally advanced breast cancer.Methods: One...

Descripció completa

Guardat en:
Autors principals: Mohammad Mohammadianpanah, Ahmad Mosalaei, Mansour Ansari, Niloofar Ahmadloo, Hamid Nasrolahi, Abdolrasoul Talei, Sedigheh Tahmasebi, Yaghoub Ashouri, Sare Hosseini, Shapour Omidvari
Format: Artigo
Idioma:Inglês
Publicat: Shiraz University of Medical Sciences 2011-04-01
Col·lecció:Middle East Journal of Cancer
Matèries:
Locally advanced breast cancer
Neoadjuvant chemotherapy
Docetaxel
Doxorubicin
Complete pathologic response
Phase III clinical trial
Accés en línia:http://mejc.sums.ac.ir/index.php/mejc/article/view/50/135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars